MyFinsight
Home
About
Contact
kalv: the income statement
Download
Download image
Unrealized holding gain on
marketable securities
$187K
Foreign currency
translation gain (loss)
$911K
Comprehensive loss
-$49,155K
Total other
comprehensive (loss) income
$327K
Reclassification adjustment for
realized holding gain on...
$771K
Net loss
-$49,482K
Income tax expense
$2,157K
Loss before income
tax expense
-$47,325K
Total other (expense)
income
-$1,275K
Operating loss
-$46,050K
Other income, net
$2,491K
Interest income
$1,875K
Product revenue, net
$13,692K
Foreign currency
exchange (loss) gain
-$884K
Interest expense
$4,757K
Total operating
expenses
$59,742K
Selling, general and
administrative
$46,517K
Research and development
$11,993K
Cost of revenue
$1,232K
Back
Back
Income Statement
source: myfinsight.com
KalVista Pharmaceuticals, Inc. (KALV)
KalVista Pharmaceuticals, Inc. (KALV)